 Introduction fetal heart rate, FHR, monitoring is a vital aspect of fetal well-being assessment, and the current method of computerized cardiotography, CCTG, is limited to the hospital setting. Non-invasive fetal ECG, NIFEC, has the ability to produce FHR patterns through a wave detection while eliminating confusion with maternal heart rate, but is presently limited to research use. Femmem is a novel wireless NIFEC device that is designed to be placed without professional assistance while connecting to mobile applications. It has the ability to achieve home FHR monitoring thereby allowing more frequent monitoring, earlier detection of deterioration, while reducing hospital attendances. This study aims to assess the feasibility, reliability, and accuracy of Femmem NIFEC by comparing its outputs to CCTG monitoring. Methods and analysis this is a single centered prospective pilot study taking place in a tertiary maternity unit. Women with a singleton pregnancy over 28 plus zero weeks gestation who require antenatal CCTG monitoring for any clinical indication are eligible for recruitment. Con. This article was authored by Amanov Bidey, Bhasky Filignathan, Becky Liu, and others. We are article.tv, links in the description below.